Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Augmentation des complications sanitaires graves lors de l’usage non-médical du protoxyde d’azote en France.
Association française des centres d’addictovigilance; Micallef J, Mallaret M, Lapeyre-Mestre M, Daveluy A, Victorri-Vigneau C, Peyrière H, Debruyne D, Deheul S, Bordet R, Chevallier C, Perault-Pochat MC, Le Boisselier R, Libert F, Chaouachi L, Gillet P. Association française des centres d’addictovigilance, et al. Among authors: le boisselier r. Therapie. 2021 Jan-Feb;76(1):53-54. doi: 10.1016/j.therap.2020.01.001. Epub 2020 Jan 17. Therapie. 2021. PMID: 32005483 French. No abstract available.
[Mephedrone: a designer drug of recent use in France].
Debruyne D, Courné MA, Le Boisselier R, Djezzar S, Gérardin M, Boucher A, Karila L, Coquerel A, Mallaret M. Debruyne D, et al. Among authors: le boisselier r. Therapie. 2010 Nov-Dec;65(6):519-24. doi: 10.2515/therapie/2010077. Epub 2010 Dec 23. Therapie. 2010. PMID: 21176758 Review. French.
[Abuse of gammabutyrolactone (GBL): a case report].
Le Boisselier R, Paillet-Loilier M, Buléon C, Debruyne D, Coquerel A. Le Boisselier R, et al. Therapie. 2011 Mar-Apr;66(2):175-7. doi: 10.2515/therapie/2011017. Therapie. 2011. PMID: 23189338 French. No abstract available.
OPPIDUM surveillance program: 20 years of information on drug abuse in France.
Frauger E, Moracchini C, Le Boisselier R, Braunstein D, Thirion X, Micallef J; French CEIPA-A Network. Frauger E, et al. Among authors: le boisselier r. Fundam Clin Pharmacol. 2013 Dec;27(6):672-82. doi: 10.1111/fcp.12024. Epub 2013 Mar 20. Fundam Clin Pharmacol. 2013. PMID: 23510229
Emerging drugs of abuse: current perspectives on substituted cathinones.
Paillet-Loilier M, Cesbron A, Le Boisselier R, Bourgine J, Debruyne D. Paillet-Loilier M, et al. Among authors: le boisselier r. Subst Abuse Rehabil. 2014 May 26;5:37-52. doi: 10.2147/SAR.S37257. eCollection 2014. Subst Abuse Rehabil. 2014. PMID: 24966713 Free PMC article. Review.
New synthetic drugs in addictovigilance.
Chavant F, Boucher A, Le Boisselier R, Deheul S, Debruyne D. Chavant F, et al. Among authors: le boisselier r. Therapie. 2015 Mar-Apr;70(2):167-89. doi: 10.2515/therapie/2015001. Epub 2015 Apr 9. Therapie. 2015. PMID: 25858573 Free article. English, French.
Comment on "A Unique Case of Cardiac Arrest following K2 Abuse".
Alexandre J, Debruyne D, Coquerel A, Le Boisselier R. Alexandre J, et al. Among authors: le boisselier r. Case Rep Cardiol. 2015;2015:739149. doi: 10.1155/2015/739149. Epub 2015 Mar 26. Case Rep Cardiol. 2015. PMID: 25883810 Free PMC article. No abstract available.
42 results